Khan, S., Chatfield, S., Stratford, R., Bedwell, J., Bentley, M., Sulsh, S., Giemza, R., Smith, S., Bongard, Emily  ORCID: https://orcid.org/0000-0001-5957-6280, Cosgrove, C. A., Johnson, J., Dougan, G., Griffin, G. E., Makin, J. and Lewis, D. J. M.
2007.
Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans.
Vaccine
25
(21)
, pp. 4175-4182.
10.1016/j.vaccine.2007.03.007
|
Abstract
We have evaluated an oral vaccine based on an Salmonella enteric serovar typhi (S. typhi) Ty2 derivative TSB7 harboring deletion mutations in ssaV (SPI-2) and aroC together with a chromosomally integrated copy of eltB encoding the B subunit of enterotoxigenic Escherichia coli heat labile toxin (LT-B) in volunteers. Two oral doses of 108 or 109 CFU were administered to two groups of volunteers and both doses were well tolerated, with no vaccinemia, and only transient stool shedding. Immune responses to LT-B and S. typhi lipopolysaccharide were demonstrated in 67 and 97% of subjects, respectively, without evidence of anti-carrier immunity preventing boosting of LT-B responses in many cases. Further development of this salmonella-based (spi-VEC) system for oral delivery of heterologous antigens appears warranted.
| Item Type: | Article |
|---|---|
| Date Type: | Publication |
| Status: | Published |
| Schools: | Schools > Medicine |
| Subjects: | R Medicine > R Medicine (General) R Medicine > RS Pharmacy and materia medica |
| Uncontrolled Keywords: | Typhoid; Salmonella; Oral vaccine; ETEC; Enterotoxigenic E. coli |
| Publisher: | Elsevier |
| ISSN: | 0264-410X |
| Last Modified: | 25 Oct 2022 08:43 |
| URI: | https://orca.cardiff.ac.uk/id/eprint/54062 |
Citation Data
Cited 35 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
 |
Edit Item |
Dimensions
Dimensions